Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents. - Wikidata - wikimedia - TriplyDB

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

http://www.wikidata.org/entity/Q34104503

about

Dendrimer advances for the central nervous system delivery of therapeutics NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space Nanoparticles for imaging and treating brain cancer Application of dental nanomaterials: potential toxicity to the central nervous system Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.Therapeutic strategies to improve drug delivery across the blood-brain barrier.Synthesis of water-soluble camptothecin-polyoxetane conjugates via click chemistry Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug.Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings.ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation Carbon nanotubes in hyperthermia therapy.Intranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice.The future of glioma treatment: stem cells, nanotechnology and personalized medicine.Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Nanofibers used for the delivery of analgesics.Nano carriers for drug transport across the blood-brain barrier.Rabies Virus-Inspired Silica-Coated Gold Nanorods as a Photothermal Therapeutic Platform for Treating Brain Tumors.Nucleic acids in human glioma treatment: innovative approaches and recent results Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood-brain barrier and enhance doxorubicin antiglioma effect.Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.

P2860

Q26828423-0C560ACA-B241-4E08-BB9A-552A7082415F Q28078448-001F876B-C1F1-4535-88FD-074AAB930133 Q28392605-B4A905F3-7676-4251-BA87-A3425E320D83 Q28394053-362632A3-B33A-4075-AD9F-49CCB279B36E Q28394487-D5B835E9-EBAD-4B74-9339-388EBA04634F Q30376531-C99AE83B-F6FE-476D-8E44-4AF9DC67DC39 Q30407443-AC09B7D1-C233-456E-ACF8-100E7860A198 Q30572775-DEA315D3-B3C9-4A12-8E26-78891E1198A8 Q34797004-C0196C6B-69ED-4B0A-992D-19843F9C2F19 Q36345289-78F5866A-4073-462E-868F-1805D84076C3 Q36486987-924FC8AB-5291-47D5-8A77-07A10FC08476 Q36941509-96B62D1E-7AE8-4F4C-B54F-DFC166C6308F Q37557801-C614190E-B973-46E2-B198-CD7E5A31D0E5 Q37711788-18017A77-FDC6-40FB-80E1-AC6D22E19BC7 Q38048888-C90C3C60-152D-4CB9-ADC1-5E3F3F2B930A Q38372996-210B35B0-36EA-42FC-8E6D-3BB879F898FD Q38522125-F2973962-1DB7-4613-BD28-3D5E26CD15AA Q38529529-9B6FE697-2CB8-4472-AA61-BEDAF50D22C6 Q38820474-23000B36-43E4-45D7-A062-64129014CCAB Q40359532-A23A7C50-2B8B-4C91-BDFB-E44050DF7E2E Q42111511-D57A2FCC-F090-4B82-A446-84964E2DC706 Q47175638-04EC56D6-79A6-4991-8325-6D82DC84B4CC Q54978120-8FC167A5-5512-4BE4-B2BE-101D49E264D2

P2860

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

http://www.wikidata.org/entity/Q34104503

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@ast

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@en

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@nl

type

label

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@ast

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@en

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@nl

prefLabel

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@ast

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@en

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@nl

P1433

Q34104503-66CD3A56-DAD3-4ACF-B577-0CA111526297

P1476

Q34104503-3340DFDC-BEA5-4A6C-9012-E5EA20110554

P2093

Q34104503-05248CCB-009A-40C8-80EB-5891F291C29A

Q34104503-1146230E-12E7-4A04-B6EC-2413B1D3F0EA

Q34104503-2239454A-DB9B-4356-B383-C3C9D7F4493D

Q34104503-2A25F443-94CC-4D60-B414-20B079DDC0A5

Q34104503-3BB9018A-3880-44D2-9A6C-853AAF1C4F11

Q34104503-7D1E5913-73FF-47CD-854B-86BE301CC8C3

Q34104503-D538D392-AC4C-4DA9-BDB8-61C5D7996A0B

P2860

Q34104503-025231DB-B0E7-47C3-B89D-87F453250A3E

Q34104503-036142B7-C1D2-42D3-BC84-3908832DCF3A

Q34104503-05BA0F70-F017-4898-A969-9F88FA3D6885

Q34104503-09675178-2A8D-4B25-BB8D-04905F0E807A

Q34104503-110F94F8-C12C-492E-AD94-85223F4E65C8

Q34104503-1476D975-7E66-4174-902A-9E948FF97649

Q34104503-1488EA90-1DD8-4B45-8E5E-D88D460FF45E

Q34104503-1AE57534-2304-4587-B1D9-B19DBF719CEC

Q34104503-1F3891D1-974E-442F-928D-B47B2E562127

Q34104503-2E09CA78-091E-481A-8F03-0DA50605FC63

P304

Q34104503-B6842833-8C88-4734-9FE0-AE239B6E56AB

P31

Q34104503-D45059D2-66F5-4BF4-933B-F4D239F068E0

P356

Q34104503-EB538A0A-CFB3-453D-8014-387497D14CC1

P407

Q34104503-3288B2D0-2A6C-4C35-BD04-99E4A51BA89B

P433

Q34104503-3EAAA728-88E8-4EEE-9B97-F474F7B099C5

P478

Q34104503-AA30A8BC-365B-4C98-AF8E-A8B12741F0CC

P577

Q34104503-808CD01D-3776-4435-91F5-40F453B1D2D5

P5875

Q34104503-DC11D052-7006-4A20-921A-7449CEB24521

P698

Q34104503-A80940D5-EFAA-43A0-A751-A587D594952E

P921

Q34104503-0F9E0720-E33D-411E-B609-6C1C7B40E436

P932

Q34104503-12883375-EE13-4F69-A8F8-6ABE3D32D807

P356

J.ADDR.2011.11.014

P1433

Advanced Drug Delivery Reviews

P1476

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

@en

P2093

Chaitali Ghosh

http://www.w3.org/2001/XMLSchema#string

Damir Janigro

http://www.w3.org/2001/XMLSchema#string

Hu Yang

http://www.w3.org/2001/XMLSchema#string

Kathy Guo

http://www.w3.org/2001/XMLSchema#string

Kristoffer Valerie

http://www.w3.org/2001/XMLSchema#string

Laura Biddlestone-Thorpe

http://www.w3.org/2001/XMLSchema#string

Nicola Marchi

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Significance of MDR1 and multiple drug resistance in refractory human epileptic brain

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Cancer statistics, 2010

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Receptor-mediated transcytosis of transferrin across the blood-brain barrier

Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics

Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers

DNA repair pathways as targets for cancer therapy

P304

605-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADDR.2011.11.014

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51897190

http://www.w3.org/2001/XMLSchema#string

P698

22178615

http://www.w3.org/2001/XMLSchema#string

P921

P932

3321130

http://www.w3.org/2001/XMLSchema#string